Nuveen
MRNA icon

Nuveen’s Moderna MRNA Stock Holding History

Nuveen’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,900
Closed -$5K – 3401
2022
Q1 		$5K Buy
+30,900
New +$5.2M ﹤0.01% 3327
2021
Q4 		– Sell
-20,600
Closed -$8K – 3380
2021
Q3 		$8K Sell
20,600
-6,800
-25% -$2.51M ﹤0.01% 3337
2021
Q2 		$6K Buy
+27,400
New +$4.9M ﹤0.01% 3299

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Nuveen's MRNA Position: Q2 2026 in Review

Nuveen reduced its Moderna (MRNA) stake by 29% in Q2 2026, selling an estimated $16.3M and leaving 762,777 shares worth $53.4M. The position accounts for 0.01% of the portfolio, ranked #670.

Nuveen first reported a position in MRNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $490M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Nuveen held 762,777 shares of Moderna worth $53.4M as of Q2 2026.
  • Nuveen sold 315,417 Moderna shares in Q2 2026, an estimated $16.3M.
  • Moderna made up 0.01% of Nuveen's portfolio in Q2 2026, its #670 holding.
  • Nuveen first reported a position in Moderna in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Moderna position peaked at $490M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.